Skystar Bio-Pharmaceutical Company Stock
Stocks
SKBI
US8308843007
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| Market Cap | 36.7M 32.28M 29.99M 27.58M 51.72M 3.55B 52.65M 359M 140M 1.73B 138M 135M 6.01B | P/E 2012 |
1.93x | P/E 2013 | 2.56x |
|---|---|---|---|---|---|
| Enterprise Value | 39.2M 34.48M 32.03M 29.46M 55.24M 3.8B 56.23M 383M 149M 1.85B 147M 144M 6.42B | EV / Sales 2012 |
0.2x | EV / Sales 2013 | 0.69x |
| Free-Float |
100% | Yield 2012 * |
-
| Yield 2013 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Tun Qu
BRD | Director/Board Member | 60 | 2008-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 0 | |
| +1.08% | -6.74% | -2.31% | +10.45% | 46.06B | |
| +3.13% | +2.34% | +393.21% | +605.08% | 38.91B | |
| +2.14% | +4.98% | +10.55% | +65.45% | 35.57B | |
| +4.43% | +0.25% | +10.64% | -9.17% | 33.13B | |
| +1.23% | -1.99% | -0.05% | +30.76% | 26.42B | |
| +0.29% | -5.92% | - | - | 16.61B | |
| +14.71% | +14.47% | +26.81% | +146.99% | 15.08B | |
| -6.32% | -4.59% | +4.36% | +8.22% | 14.08B | |
| +1.82% | -1.02% | +5.46% | -30.74% | 12.81B | |
| Average | +2.10% | -1.91% | +56.08% | +103.38% | 23.87B | |
| Weighted average by Cap. | +2.22% | -2.47% | +74.11% | +129.70% |
| 2012 | 2013 | |
|---|---|---|
| Net sales | 33.59M 29.54M 27.44M 25.24M 47.33M 3.25B 48.18M 328M 128M 1.59B 126M 123M 5.5B | 42.48M 37.36M 34.71M 31.92M 59.87M 4.11B 60.94M 415M 162M 2.01B 159M 156M 6.96B |
| Net income | 6.21M 5.46M 5.08M 4.67M 8.75M 602M 8.91M 60.7M 23.67M 293M 23.32M 22.82M 1.02B | 10.53M 9.26M 8.6M 7.91M 14.84M 1.02B 15.11M 103M 40.13M 497M 39.53M 38.68M 1.73B |
| Net Debt | -5.61M -4.93M -4.58M -4.21M -7.9M -543M -8.05M -54.8M -21.37M -265M -21.06M -20.6M -919M | 2.5M 2.2M 2.04M 1.88M 3.52M 242M 3.58M 24.41M 9.52M 118M 9.38M 9.18M 409M |
Employees
-
- Stock Market
- Stocks
- SKBI Stock
Select your edition
All financial news and data tailored to specific country editions
